MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration Covid et maladies cardiovasculaires - Exploration (Accueil)

Index « MeshFr.i » - entrée « Système rénine-angiotensine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Système cardiovasculaire < Système rénine-angiotensine < Séquence nucléotidique  Facettes :

List of bibliographic references indexed by Système rénine-angiotensine

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000007 (2020) Awadhesh Kumar Singh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde]Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.
000033 (2020) Francisco J. De Abajo [Espagne] ; Sara Rodríguez-Martín [Espagne] ; Victoria Lerma [Espagne] ; Gina Mejía-Abril [Espagne] ; M Nica Aguilar [Espagne] ; Amelia García-Luque [Espagne] ; Leonor Laredo [Espagne] ; Olga Laosa [Espagne] ; Gustavo A. Centeno-Soto [Espagne] ; Maria Ángeles Gálvez [Espagne] ; Miguel Puerro [Espagne] ; Esperanza González-Rojano [Espagne] ; Laura Pedraza [Espagne] ; Itziar De Pablo [Espagne] ; Francisco Abad-Santos [Espagne] ; Leocadio Rodríguez-Ma As [Espagne] ; Miguel Gil [Espagne] ; Aurelio Tobías [Espagne] ; Antonio Rodríguez-Miguel [Espagne] ; Diego Rodríguez-Puyol [Espagne]Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
000099 (2020) Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France]Renin-angiotensin system at the heart of COVID-19 pandemic.
000100 (2020) Giuseppe Mancia ; Federico Rea ; Monica Ludergnani ; Giovanni Apolone ; Giovanni CorraoRenin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19.
000101 (2020) Jordana B. Cohen [États-Unis] ; Thomas C. Hanff [États-Unis] ; Adam P. Bress [États-Unis] ; Andrew M. South [États-Unis]Relationship Between ACE2 and Other Components of the Renin-Angiotensin System.
000172 (2020) Virna Margarita Martín Giménez [Argentine] ; Felipe Inserra [Argentine] ; Carlos D. Tajer [Argentine] ; Javier Mariani [Argentine] ; Le N Ferder [Argentine] ; Russel J. Reiter [États-Unis] ; Walter Manucha [Argentine]Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment.
000202 (2020) Himanshu Sankrityayan [Inde] ; Ajinath Kale [Inde] ; Nisha Sharma [Inde] ; Hans-Joachim Anders [Allemagne] ; Anil Bhanudas Gaikwad [Inde]Evidence for Use or Disuse of Renin-Angiotensin System Modulators in Patients Having COVID-19 With an Underlying Cardiorenal Disorder.
000235 (2020) Francesco P. Cappuccio [Royaume-Uni] ; Alfonso Siani [Italie]Covid-19 and cardiovascular risk: Susceptibility to infection to SARS-CoV-2, severity and prognosis of Covid-19 and blockade of the renin-angiotensin-aldosterone system. An evidence-based viewpoint.
000239 (2020) Di Liu [République populaire de Chine] ; Yun-Zhao Li [République populaire de Chine] ; Hui Wu [République populaire de Chine]Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?
000272 (2020) Xian Zhou [République populaire de Chine] ; Jingkang Zhu [République populaire de Chine] ; Tao Xu [République populaire de Chine]Clinical characteristics of coronavirus disease 2019 (COVID-19) patients with hypertension on renin-angiotensin system inhibitors.
000276 (2020) Agnieszka Brojakowska [États-Unis] ; Jagat Narula [États-Unis] ; Rony Shimony [États-Unis] ; Jeffrey Bander [États-Unis]Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
000281 (2020) Iziah E. Sama [Pays-Bas] ; Alice Ravera [Pays-Bas, Italie] ; Bernadet T. Santema [Pays-Bas] ; Harry Van Goor [Pays-Bas] ; Jozine M. Ter Maaten [Pays-Bas] ; John G F. Cleland [Royaume-Uni] ; Michiel Rienstra [Pays-Bas] ; Alex W. Friedrich [Pays-Bas] ; Nilesh J. Samani [Royaume-Uni] ; Leong L. Ng [Royaume-Uni] ; Kenneth Dickstein [Norvège] ; Chim C. Lang [Royaume-Uni] ; Gerasimos Filippatos [Grèce, Chypre (pays)] ; Stefan D. Anker [Allemagne] ; Piotr Ponikowski [Pologne] ; Marco Metra [Italie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Adriaan A. Voors [Pays-Bas]Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
000285 (2020) Yi He [République populaire de Chine] ; Jinfeng Wei [République populaire de Chine] ; Jinjun Bian [République populaire de Chine] ; Kefang Guo [République populaire de Chine] ; Jiakai Lu [République populaire de Chine] ; Wei Mei [République populaire de Chine] ; Jun Ma [République populaire de Chine] ; Zhongyuan Xia [République populaire de Chine] ; Meiying Xu [République populaire de Chine] ; Fuxia Yan [République populaire de Chine] ; Chunhua Yu [République populaire de Chine] ; E. Wang [République populaire de Chine] ; Weijian Wang [République populaire de Chine] ; Ni Zeng [République populaire de Chine] ; Sheng Wang [République populaire de Chine] ; Junmei Xu [République populaire de Chine] ; Yuguang Huang [République populaire de Chine] ; Jiapeng Huang [États-Unis]Chinese Society of Anesthesiology Expert Consensus on Anesthetic Management of Cardiac Surgical Patients With Suspected or Confirmed Coronavirus Disease 2019.
000308 (2020) Leo F. Buckley [États-Unis] ; Judy W M. Cheng [États-Unis] ; Akshay Desai [États-Unis]Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
000313 (2020) Chia Siang Kow [Malaisie] ; Syed Tabish Razi Zaidi [Royaume-Uni] ; Syed Shahzad Hasan [Royaume-Uni]Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.
000334 (2020) Marijana Tadic [Serbie] ; Cesare Cuspidi [Italie] ; Giuseppe Mancia [Italie] ; Raffaella Dell'Oro [Italie] ; Guido Grassi [Italie]COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
000362 (2020) Anne-Sophie Boureau [France] ; Laure De Decker [France] ; Gilles Berrut [France] ; Olivier Hanon [France]COVID-19 and cardiovascular diseases: viewpoint for older patients.
000388 (2020) Mahmoud Gheblawi ; Kaiming Wang ; Anissa Viveiros ; Quynh Nguyen ; Jiu-Chang Zhong ; Anthony J. Turner [Royaume-Uni] ; Mohan K. Raizada ; Maria B. Grant ; Gavin Y. OuditAngiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2.
000397 (2020) Andrew M. South [États-Unis] ; Tammy M. Brady ; Joseph T. FlynnACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Système rénine-angiotensine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Système rénine-angiotensine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Système rénine-angiotensine
}}
Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021